Retail Media Confessions, Episode 2: Rethinking ROAS

Retail media is built on measurement—but not all metrics drive the outcomes brands actually need. As investment grows, so does the pressure to prove performance, and too often that performance is reduced to a single number: ROAS.

• Read more about Retail Media Confessions, Episode 2: Rethinking ROAS

Serialization in Pharmaceutical Returns Is Creating New Expectations

Serialization has reshaped how pharmaceuticals move through the supply chain. Much of the attention has focused on outbound distribution and regulatory compliance, but returns are increasingly part of the picture as well.

• Read more about Serialization in Pharmaceutical Returns Is Creating New Expectations

Why Pharmaceutical Returns Policies Are Becoming More Complex

Pharmaceutical returns have never been simple, but the rules that govern them are becoming more complicated each year. What once relied on a relatively small set of manufacturer guidelines has expanded into a patchwork of policies that vary by product, timing and eligibility.

• Read more about Why Pharmaceutical Returns Policies Are Becoming More Complex

Three’s Company, Four’s Excluded: Structural Gaps in the FTC–Express Scripts Settlement

By Lari Harding, SVP, Industry Affairs & Strategic Partnerships, Inmar Intelligence The Federal Trade Commission (FTC) has proposed a consent order with Express Scripts (ESI), one of the nation’s largest pharmacy benefit managers (PBMs), to resolve allegations related to insulin pricing practices and broader competition concerns.

• Read more about Three’s Company, Four’s Excluded: Structural Gaps in the FTC–Express Scripts Settlement

Transform Sports Fan Data Into a Scalable Fan Engagement Solution

Modern sports organizations sit on a wealth of fan data, but data alone doesn’t create loyalty, sell tickets, or grow sponsorship revenue. What does? A fan engagement platform that turns insight into timely, relevant experiences across every touchpoint.

• Read more about Transform Sports Fan Data Into a Scalable Fan Engagement Solution

What the Latest Data Shows About Unsaleable Returns

Pharmaceutical returns are often treated as a routine task. Products expire, recalls happen and inventory is cleared out as needed. But recent data shows that unsaleable returns are more than an operational chore. They offer insight into financial performance, compliance risk and how well pharmacy operations are keeping up with a changing supply chain.

• Read more about What the Latest Data Shows About Unsaleable Returns

2026 NoLo Alcohol Report

Our 2026 NoLo Trends Report explores 3 trends influencing category growth and what they mean for planning in the year ahead.

• Read more about 2026 NoLo Alcohol Report

Credit Assurance Plus: Turning Pharmacy Returns Into Strategic Reinvestment

Pharmacy returns have long been viewed as a necessary operational task rather than a strategic opportunity. As healthcare organizations face continued margin pressure, staffing challenges, and increasing regulatory complexity, that perspective is starting to shift.

• Read more about Credit Assurance Plus: Turning Pharmacy Returns Into Strategic Reinvestment

What’s Next for DSCSA: moving from “live” to truly operational

As DSCSA shifts from go-live to daily execution, dispensers are focusing on operational readiness across receiving, reconciliation, transfers and audit documentation. Success now depends on consistent workflows, strong SOPs and tools like RxTransparent that support confident, site-level execution.

• Read more about What’s Next for DSCSA: moving from “live” to truly operational